Browsing by Contributors Hyman, David M

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 11 of 11
PreviewIssue DateTitleContributor(s)
2017 JCLIONC Volume 35 Issue 20 July (7).pdf.jpg2017AKT Inhibition in Solid Tumors With AKT1 MutationsHyman, David M; Smyth, Lillian M; Donoghue, Mark T A; Westin, Shannon N; Bedard, Philippe L; Emma, J; Bando, Hideaki; El-khoueiry, Anthony B; Mita, Alain; Schellens, Jan H M; Matthew, T; Reichel, Jonathan B; Bouvier, Nancy; Selcuklu, S Duygu; Soumerai, Tara E; Torrisi,
2016 JAMIA Volume 23 Issue 4 July (15).pdf.jpg2016Automated eligibility screening and monitoring for genotype-driven precision oncology trialsEubank, Michael H; Hyman, David M; Kanakamedala, Amritha D; Gardos, Stuart M; Wills, Jonathan M; Stetson, Peter D
JCO 2017 Volume 35 Issue 3 January (3).pdf.jpg2017Basket Trials in Oncology : A Trade-Off Between Complexity and Ef fi ciencyCunanan, Kristen M; Gonen, Mithat; Shen, Ronglai; Hyman, David M; Riely, Gregory J; Begg, Colin B; Iasonos, Alexia
GYNONC 2017 Voluem 144 Issue 1 January (1).pdf.jpg2017Gynecologic Oncology A phase 2 study of alisertib ( MLN8237 ) in recurrent or persistent uterine leiomyosarcoma : An NRG Oncology / Gynecologic Oncology Group study 0231D ☆Hyman, David M; Sill, Michael W; Lankes, Heather A; Piekarz, Richard; Shahin, Mark S; Ridgway, Mildred R; Backes, Floor; Tenney, Meaghen E; Mathews, Cara A; Hoffman, James S; Aghajanian, Carol; Hensley, Martee L
2018 Nature Volume 554 Issue 7691 February (45).pdf.jpg2018HER kinase inhibition in patients withHyman, David M; Piha-paul, Sarina A; Won, Helen; Rodon, Jordi; Saura, Cristina; Shapiro, Geoffrey I; Juric, Dejan; Quinn, David I; Moreno, Victor; Doger, Bernard; Mayer, Ingrid A; Boni, Valentina; Calvo, Emiliano; Loi, Sherene; Scaltriti, Maurizio; Ulaner, Gary A; Patel,
2016 JNM Volume 57 Issue 10 October (28).pdf.jpg2016HER2-Negative Primary Breast Cancer UsingCt, Zr-trastuzumab P E T; Ulaner, Gary A; Hyman, David M; Ross, Dara S; Corben, Adriana; Chandarlapaty, Sarat; Goldfarb, Shari; Mcarthur, Heather; Erinjeri, Joseph P; Solomon, Stephen B; Kolb, Hartmuth; Lyashchenko, Serge K; Lewis, Jason S; Carrasquillo, Jorge A; Pet,
2017 JCCPsychology Volume 85 Issue 9 September (2).pdf.jpg2017Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline TestingMandelker, Diana; Zhang, Liying; Kemel, Yelena; Stadler, Zsofia K; Joseph, Vijai; Zehir, Ahmet; Pradhan, Nisha; Arnold, Angela; Walsh, Michael F; Li, Yirong; Balakrishnan, Anoop R; Syed, Aijazuddin; Prasad, Meera; Nafa, Khedoudja; Carlo, Maria I; Cadoo, Karen A; Sheehan, Meg; Fleischut, Megan H; Salo-mullen, Erin; Trottier, Magan; Lipkin, Steven M; Lincoln, Anne; Mukherjee, Semanti; Ravichandran, Vignesh; Cambria, Roy; Galle, Jesse; Abida, Wassim; Arcila, Marcia E; Benayed, Ryma; Shah, Ronak; Yu, Kenneth; Bajorin, Dean F; Coleman, Jonathan A; Leach, Steven D; Lowery, Maeve A; Garcia-aguilar, Julio; Kantoff, Philip W; Sawyers, Charles L; Dickler, Maura N; Saltz, Leonard; Motzer, Robert J; Reilly, Eileen M O; Scher, Howard I; Baselga, Jose; Klimstra, David S; Solit, David B; Hyman, David M; Berger, Michael F; Ladanyi, Marc; Robson, Mark E; Offit, Kenneth
2017 NEJM Volume 376 Issue 8 February (17).pdf.jpg2017Niraparib in Recurrent Ovarian CancerSchram, Alison M; Aghajanian, Carol A; Hyman, David M
2017 AJoSP Volume 41 Issue 11 November (13).pdf.jpg2017Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK FusionsHechtman, Jaclyn F; Benayed, Ryma; Hyman, David M; Drilon, Alexander; Zehir, Ahmet; Frosina, Denise; Arcila, Maria E; Dogan, Snjezana; Klimstra, David S; Ladanyi, Marc; Jungbluth, Achim A
2016 JCO Volume 34 Issue 36 December (23).pdf.jpg2016Picking the Right Patient for Human Epidermal Growth Factor Receptor 3 – Targeted Therapy in Platinum-Resistant Ovarian CancerSchram, Alison M; Iasonos, Alexia; Hyman, David M; Sloan, Memorial; Cancer, Kettering; York, New
726.pdf.jpg20-Aug-2015Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 MutationsHyman, David M; Puzanov, Igor; Subbiah, Vivek; Faris, Jason E; Chau, Ian; Blay, Jean-Yves; Wolf, Jürgen; Raje, Noopur S; Diamond, Eli L; Hollebecque, Antoine; Gervais, Radj; Elez-Fernandez, Maria Elena; Italiano, Antoine; Hofheinz, Ralf-Dieter; Hidalgo, Manuel; Chan, Emily; Schuler, Martin; Lasserre, Susan Frances; Makrutzki, Martina; Sirzen, Florin; Veronese, Maria Luisa; Tabernero, Josep; Baselga, José